Condensed Consolidated Statements of Operations (Unaudited) - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2017	Oct. 01, 2016	Sep. 30, 2017	Oct. 01, 2016
Income Statement [Abstract]
Sales, net		$ 6,084,690	$ 3,937,286	$ 13,670,646	$ 17,211,865
Cost of sales		3,169,321	2,074,325	7,028,340	8,831,400
Gross profit		2,915,369	1,862,961	6,642,306	8,380,465
Operating expenses:
Sales and marketing		1,103,157	286,941	2,058,178	1,190,013
Research and development		1,040,561	772,799	2,554,713	1,988,597
General and administrative		3,948,435	1,727,383	8,882,821	5,935,139
Other		0	0	745,773	0
Operating expenses		6,092,153	2,787,123	14,241,485	9,113,749
Operating loss		(3,176,784)	(924,162)	(7,599,179)	(733,284)
Nonoperating expense:
Interest expense, net		(44,508)	(2,260)	(108,751)	(314,926)
Loss on debt extinguishment		0	0	0	(313,099)
Nonoperating expenses		(44,508)	(2,260)	(108,751)	(628,025)
Loss before income taxes				(7,707,930)	(1,361,309)
Provision for taxes				0	(3,500)
Loss from continuing operations		(3,221,292)	(926,422)	(7,707,930)	(1,364,809)
Income (loss) from discontinued operations		(108,899)	(31,121)	(315,140)	583,377
Gain on sale of discontinued operations		5,467,268	0	5,467,268	0
Provision for taxes		0	3,153	0	0
Income (loss) from discontinued operations, net		5,358,369	(27,968)	5,152,128	583,377
Net income (loss)		$ 2,137,077	$ (954,390)	$ (2,555,802)	$ (781,432)
Basic earnings (loss) per common share: continuing operations		$ (0.07)	$ (0.02)	$ (.18)	$ (.04)
Basic earnings (loss) per common share: discontinued operations		.12	(0.01)	.12	.002
Basic earnings (loss) per common share		.05	(0.03)	(0.06)	(0.02)
Diluted earnings (loss) per common share: continuing operations		(0.07)	(0.02)	(.18)	(.04)
Diluted earnings (loss) per common share: discontinued operations		0.11	(0.01)	.12	.02
Diluted earnings (loss) per common share		$ 0.04	$ (0.03)	$ (0.06)	$ (0.02)
Basic weighted average common shares outstanding	[1]	47,065,009	37,868,672	42,405,616	37,090,916
Diluted weighted average common shares outstanding		47,556,697	37,868,672	42,405,616	37,090,916

[1] Includes approximately 0.5 million weighted average nonvested shares of restricted stock for the three and nine month periods ending September 30, 2017, respectively, and approximately 0.4 million weighted average nonvested shares or restricted stock for the three and nine month periods ending October 1, 2016, respectively. These shares are participating securities that feature voting and dividend rights.